Pharma shares on a roll on strong growth prospects

Sun Pharma, Ranbaxy, Lupin and Glenmark Pharma gained more than 40% in past three months.

Shares of pharmaceutical companies continued their upward march with most of the frontline stocks are trading at their lifetime highs after reporting healthy results for the June quarter. Analysts believe that the the Indian pharma market is likely to report a double-digit growth going ahead. Sun Pharmaceutical Industries, Ranbaxy Laboratories, Cipla, Lupin, Aurobindo Pharma, Divi’s Laboratories, Abbott India, Torrent Pharmaceuticals and Shasun Pharmaceuticals have hits their respective new highs on the Bombay Stock Exchange (BSE) during intra-day deals on ...